2 курс / Нормальная физиология / ТЕХНОЛОГИИ_ДИАГНОСТИКИ_И_КОРРЕКЦИИ_ИММУНОМЕТАБОЛИЧЕСКИХ_НАРУШЕНИЙ

171.Dean M.J., Ochoa J.B., Sanchez-Pino M.D., Zabaleta J., Garai J., Del Valle L., Wyczechowska D., Baiamonte L.B., Philbrook P., Majumder R., Vander Heide R.S., Dunkenberger L., Thylur R.P., Nossaman B., Roberts W.M., Chapple A.G., Wu J., Hicks C., Collins J., Luke B., Johnson R., Koul H.K., Rees C.A., Morris C.R., Garcia-Diaz J., Ochoa A.C. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells // Front. Immunol.‒2021.‒Vol. 12.‒695972.

172.DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer:

metabolic reprogramming fuels cell growth and proliferation // Cell. Metab. 2008. Vol. 7, no. 1. P. 11-20.

173. Desousa B.R., Kim K.K., Jones A.E., Ball A.B., Hsieh W.Y., Swain P., Morrow D.H., Brownstein A.J., Ferrick D.A., Shirihai O.S., Neilson A., Nathanson D.A., Rogers G.W., Dranka B.P., Murphy A.N., Affourtit C., Bensinger S.J., Stiles L., Romero N., Divakaruni A.S. Calculation of ATP production rates using the Seahorse XF Analyzer // EMBO Rep. 2023. e56380.

174. Dias S.S.G., Soares V.C., Ferreira A.C., Sacramento C.Q., Fintelman-Rodrigues N., Temerozo J.R., Teixeira L., Nunes da Silva M.A., Barreto E., Mattos M., de Freitas C.S., Azevedo-Quintanilha I.G., Manso P.P.A., Miranda M.D., Siqueira M.M., Hottz E.D., Pão C.R.R., Bou-Habib D.C., Barreto-Vieira D.F., Bozza F.A., Souza T.M.L, Bozza P.T. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators // PLoS Pathog. 2020. Vol. 16, no. 12. e1009127.

175. Diem S., Kasenda B., Spain L., Martin-Liberal J., Marconcini R., Gore M., Larkin J. Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma // Br. J. Cancer. 2016. Vol. 114, no. 3. P. 256-261.

176.Dolgushin M.V. Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes // Bull. Exp. Biol. Med. 2020. Vol. 168, no. 4. P. 470-473.

177.Donnelly R.P., Loftus R.M., Keating S.E., Liou K.T., Biron C.A., Gardiner C.M., Finlay D.K.

mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function // J. Immunol. 2014. Vol. 193, no. 9. P. 4477-4484.

178.Dos Santos D.R., Souza R.O., Dias L.B., Ribas T.B., de Oliveira L.C.F., Sumida D.H., Dornelles R.C.M., Nakamune A.C.M.S., Chaves-Neto A.H. The effects of storage time and temperature on the stability of salivary phosphatases, transaminases and dehydrogenase // Arch.

Oral. Biol. 2018. Vol. 85. P. 160-165.

179. Doughty C.A., Bleiman B.F., Wagner D.J., Dufort F.J., Mataraza J.M., Roberts M.F., Chiles T.C. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth // Blood. 2006. Vol. 107, no. 11. P. 4458-4465.

180. Dufort F.J., Gumina M.R., Ta N.L., Tao Y., Heyse S.A., Scott D.A., Richardson A.D., Seyfried T.N., Chiles T.C. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation // J. Biol. Chem. 2014. Vol. 289, no. 10. P. 7011-7024.

181. Entrenas Castillo M., Entrenas Costa L.M., Vaquero Barrios J.M., Alcalá Díaz J.F., López Miranda J., Bouillon R., Quesada Gomez J.M. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study // J. Steroid. Biochem. Mol. Biol. 2020. Vol. 203. 105751.

182. Evans R.M., Lippman S.M. Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing // Cell. Metab. 2020. Vol. 32, no. 5. P. 704-709.

430

https://t.me/medicina_free

183. Everts B., Amiel E., Huang S.C., Smith A.M., Chang C.H., Lam W.Y., Redmann V., Freitas T.C., Blagih J., van der Windt G.J., Artyomov M.N., Jones R.G., Pearce E.L., Pearce E.J. TLRdriven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation // Nat. Immunol. 2014. Vol. 15, no. 4. P. 323-332.

184.Eweas A.F., Allam G. Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target // Mol. Biochem. Parasitol.‒2018.‒Vol. 225.‒P. 94-102.

185.Fajgenbaum D.C., Rader D.J. Teaching Old Drugs New Tricks: Statins for COVID-19? // Cell Metab.‒2020.‒Vol. 32, no. 2.‒P. 145-147.

186.Fallah J., Rini B.I. HIF Inhibitors: Status of Current Clinical Development // Curr. Oncol. Rep.‒2019.‒Vol. 21, no. 1.‒P. 6.

187.Fan S.N., Li X.Q., Ma F.H., Yang M.H., Su J., Chen X. Sulfur quantum dot based fluorescence assay for lactate dehydrogenase activity detection // J. Photoch. Photobio. A.‒2022.‒Vol. 430.‒ 113989.

188.Farjana M., Moni A., Sohag A.A.M., Hasan A., Hannan M.A., Hossain M.G., Uddin M.J. Repositioning Vitamin C as a Promising Option to Alleviate Complications associated with COVID-19 // Infect. Chemother.‒2020.‒Vol. 52, no. 4.‒P. 461-477.

189.Fatemi A., Ardehali S.H., Eslamian G., Noormohammadi M., Malek S. Association of vitamin D deficiency with COVID-19 severity and mortality in Iranian people: a prospective observational study // Acute Crit. Care.‒2021.‒Vol. 36, no. 4.‒P. 300-307.

190.Fath M.K., Naderi M., Hamzavi H., Ganji M., Shabani S., Ghahroodi F.N., Khalesi B., Pourzardosht N., Hashemi Z.S., Khalili S. Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients // J. Trace Elem. Med. Biol.‒2022.‒Vol. 73.‒127044.

191.Feingold K.R., Grunfeld C. Effect of inflammation on HDL structure and function // Curr. Opin. Lipidol.‒2016.‒Vol. 27, no. 5.‒P. 521-530.

192.Feingold K.R., Shigenaga J.K., Kazemi M.R., McDonald C.M., Patzek S.M., Cross A.S., Moser A., Grunfeld C. Mechanisms of triglyceride accumulation in activated macrophages // J.

Leukoc. Biol. 2012. Vol. 92, no. 4. P. 829-839.

193.Fiorentino G., Coppola A., Izzo R., Annunziata A., Bernardo M., Lombardi A., Trimarco V., Santulli G., Trimarco B. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis // EClinicalMedicine.‒2021.‒Vol. 40.‒101125.

194.Folkes L.K., Patel K.B., Wardman P., Wrona M. Kinetics of reaction of nitrogen dioxide with dihydrorhodamine and the reaction of the dihydrorhodamine radical with oxygen: implications

for quantifying peroxynitrite formation in cells // Arch. Biochem. Biophys. 2009. Vol. 484, no 2. P. 122-126.

195.Forcados C., Joaquina S., Casey N.P., Caulier B., Wälchli S. How CAR T Cells Breathe // Cells.‒2022.‒Vol. 11, no. 9.‒P. 1454.

196.Forman H.J., Zhang H., Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis // Mol. Aspects Med.‒2009.‒Vol. 30, no. 1-2.‒P. 1-12.

197.Fowler A.A. 3rd., Syed A.A., Knowlson S., Sculthorpe R., Farthing D., DeWilde C., Farthing C.A., Larus T.L., Martin E., Brophy D.F., Gupta S.; Medical Respiratory Intensive Care Unit Nursing; Fisher B.J., Natarajan R. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis // J. Transl. Med.‒2014.‒Vol. 12.‒P. 32.

198.Frank L.A. Ca2+-regulated photoproteins: effective immunoassay reporters // Sensors (Basel).‒2010.‒Vol. 10, no. 12.‒P. 11287-11300.

199.Frank L.A., Petunin A.I., Vysotski E.S. Bioluminescent immunoassay of thyrotropin and thyroxine using obelin as a label // Anal. Biochem.‒2004.‒Vol. 325, no. 2.‒P. 240-246.

200.Fregni M., Ciribilli Y., Zawacka-Pankau J.E. The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer // Int. J. Mol.

Sci. 2022. Vol. 23, no. 13. P. 7213.

431

https://t.me/medicina_free

201.Freigang S., Ampenberger F., Weiss A., Kanneganti T.D., Iwakura Y., Hersberger M., Kopf M. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and

sterile vascular inflammation in atherosclerosis // Nat. Immunol. 2013. Vol. 14, no. 10. P. 10451053.

202.Fu W., Cai R., Ma Z., Li T., Lei C., Zhao J., Hu S. TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance // Front. Immunol.‒2021.‒Vol. 12.‒649135.

203.Fujii T., Luethi N., Young P.J., Frei D.R., Eastwood G.M., French C.J., Deane A.M., Shehabi Y., Hajjar L.A., Oliveira G., Udy A.A., Orford N., Edney S.J., Hunt A.L., Judd H.L., Bitker L., Cioccari L., Naorungroj T., Yanase F., Bates S., McGain F., Hudson E.P., Al-Bassam W., Dwivedi D.B., Peppin C., McCracken P., Orosz J., Bailey M., Bellomo R.; VITAMINS Trial Investigators. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial // JAMA.‒2020.‒Vol. 323, no. 5.‒P. 423-431.

204.Furuya A., Uozaki M., Yamasaki H., Arakawa T., Arita M., Koyama A.H. Antiviral effects of ascorbic and dehydroascorbic acids in vitro // Int. J. Mol. Med.‒2008.‒Vol. 22, no. 4.‒P. 541455.

205.Ganjali S., Bianconi V., Penson P.E., Pirro M., Banach M., Watts G.F., Sahebkar A. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone // Metabolism.‒2020.‒Vol. 113.‒154375.

206.Gargett T., Brown M.P. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2 // Cytotherapy.‒2015.‒Vol. 17, no. 4.‒P. 487-95.

207.Geiger R., Rieckmann J.C., Wolf T., Basso C., Feng Y., Fuhrer T., Kogadeeva M., Picotti P., Meissner F., Mann M., Zamboni N., Sallusto F., Lanzavecchia A. L-Arginine Modulates T Cell

Metabolism and Enhances Survival and Anti-tumor Activity // Cell. 2016. Vol. 167, no. 3. P. 829-842.

208. Georgakopoulou V.E., Mantzouranis K., Damaskos C., Karakou E., Melemeni D., Mermigkis D., Petsinis G., Sklapani P., Trakas N., Tsiafaki X. Correlation Between Serum Levels of 25Hydroxyvitamin D and Severity of Community-Acquired Pneumonia in Hospitalized Patients Assessed by Pneumonia Severity Index: An Observational Descriptive Study // Cureus. 2020. Vol. 12, no. 7. e8947.

209. Gerriets V.A., Kishton R.J., Nichols A.G., Macintyre A.N., Inoue M., Ilkayeva O., Winter P.S., Liu X., Priyadharshini B., Slawinska M.E., Haeberli L., Huck C., Turka L.A., Wood K.C., Hale L.P., Smith P.A., Schneider M.A., MacIver N.J., Locasale J.W., Newgard C.B., Shinohara M.L., Rathmell J.C. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation // J. Clin. Invest. 2015. Vol. 125, no. 1. P. 194-207.

210.Ghasemi M., Abbasi L., Ghanbari Naeini L., Kokabian P., Nameh Goshay Fard N., Givtaj N. Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy // Front. Immunol.‒2023.‒Vol. 13.‒950079.

211.Gil-Etayo F.J., Suàrez-Fernández P., Cabrera-Marante O., Arroyo D., Garcinuño S., Naranjo L., Pleguezuelo D.E, Allende L.M., Mancebo E., Lalueza A., Díaz-Simón R., Paz-Artal E., Serrano A. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression //

Front. Cell. Infect. Microbiol. 2021. Vol. 11. 624483.

212.Giustina A. Hypovitaminosis D and the endocrine phenotype of COVID-19 // Endocrine. 2021. Vol. 72, no. 1. P. 1-11.

213.Goërtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., van Loon N., Hajian B., Spies Y., Vijlbrief H., van 't Hul A.J., Janssen D.J.A., Spruit M.A. Persistent symptoms 3 months after a

SARS-CoV-2 infection: the post-COVID-19 syndrome? // ERJ Open Res. 2020. Vol. 6, no. 4. P. 00542-2020.

432

https://t.me/medicina_free

214. Goldberg E.L., Molony R.D., Kudo E., Sidorov S., Kong Y., Dixit V.D., Iwasaki A. Ketogenic diet activates protective γδ T cell responses against influenza virus infection // Sci. Immunol. 2019. Vol. 4, no. 41. eaav2026.

215. Golovkin A., Kalinina O., Bezrukikh V., Aquino A., Zaikova E., Karonova T., Melnik O., Vasilieva E., Kudryavtsev I. Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19 // Viruses. 2021. Vol. 13. P. 1966.

216.Gomez-Eerland R., Nuijen B., Heemskerk B., van Rooij N., van den Berg J.H., Beijnen J.H., Uckert W., Kvistborg P., Schumacher T.N., Haanen J.B., Jorritsma A. Manufacture of genemodified human T-cells with a memory stem/central memory phenotype // Hum. Gene Ther. Methods.‒2014.‒Vol. 25, no. 5.‒P. 277-287.

217.Goncalves M.D., Cantley L.C. A Glycolysis Outsider Steps into the Cancer Spotlight // Cell.

Metab. 2018. Vol. 28, no. 1. P. 3-4.

218. Gönen M.S., Alaylıoğlu M., Durcan E., Özdemir Y., Şahin S., Konukoğlu D., Nohut O.K., Ürkmez S., Küçükece B., Balkan İ.İ., Kara H.V., Börekçi Ş., Özkaya H., Kutlubay Z., Dikmen Y., Keskindemirci Y., Karras S.N., Annweiler C., Gezen-Ak D., Dursun E. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-

2)Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1 // Nutrients. 2021. Vol. 13, no. 11. P. 4047.

219.Goodman K.E., Magder L.S., Baghdadi J.D., Pineles L., Levine A.R., Perencevich E.N., Harris A.D. Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-

19)Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals // Clin.

Infect. Dis. 2021. Vol. 73, no. 11. e4113-e4123.

220. Gotlieb N., Tachlytski I., Lapidot Y., Sultan M., Safran M., Ben-Ari Z. Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D- dependent inhibition of viral transcription and production // Mol. Med. 2018. Vol. 24, no. 1. P. 53.

221.Grangé S., Bekri S., Artaud-Macari E., Francois A., Girault C., Poitou A.L., Benhamou Y., Vianey-Saban C., Benoist J.F., Châtelet V., Tamion F., Guerrot D. Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency // Lancet.‒ 2015.‒Vol. 386, no. 9997.‒P. 1011-1012.

222.Grant W.B., Al Anouti F., Boucher B.J, Dursun E., Gezen-Ak D., Jude E.B., Karonova T., Pludowski P. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D

Concentration Thresholds for Optimal Health // Nutrients. 2022. Vol. 14, no. 3. P. 639.

223. Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano J.L., Bhattoa H.P. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths // Nutrients. 2020. Vol. 12, no. 4. P. 988.

224.Grimes J.M., Khan S., Badeaux M., Rao R.M., Rowlinson S.W., Carvajal R.D. Arginine depletion as a therapeutic approach for patients with COVID-19 // Int. J. Infect. Dis. 2021. Vol. 102. P. 566-570.

225.Gubser P.M., Bantug G.R., Razik L., Fischer M., Dimeloe S., Hoenger G., Durovic B., Jauch A., Hess C. Rapid effector function of memory CD8+ T cells requires an immediate-early

glycolytic switch // Nat. Immunol. 2013. Vol. 14, no. 10. P. 1064-1072.

226.Guerra E., Di Pietro R., Basile M., Trerotola M., Alberti S. Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics // Int. J. Mol. Sci.‒2021.‒Vol. 23, no. 1.‒P. 405.

227.Guerra L., Bonetti L., Brenner D. Metabolic Modulation of Immunity: A New Concept in

Cancer Immunotherapy // Cell. Rep. 2020. Vol. 32, no. 1. 107848.

228.Gulic T., Laskarin G., Glavan L., Grubić Kezele T., Haller H., Rukavina D. Human Decidual CD1a+ Dendritic Cells Undergo Functional Maturation Program Mediated by Gp96 // Int. J. Mol. Sci.‒2023.‒Vol. 24, no. 3.‒P. 2278.

229.Haddock S.H., Moline M.A., Case J.F. Bioluminescence in the sea // Ann. Rev. Mar. Sci.‒ 2010.‒Vol. 2.‒P. 443-493.

433

https://t.me/medicina_free

230.Hallett M.B., Campbell A.K. Direct measurement of intracellular free Ca2+ in rat peritoneal macrophages: correlation with oxygen-radical production // Immunology.‒1983.‒Vol. 50, no. 3.‒ P. 487-495.

231.Halvorsen C.P., Olson L., Araújo A.C., Karlsson M., Nguyễn T.T., Khu D.T.K., Le H.T.T., Nguyễn H.T.B., Winbladh B., Russom A. A rapid smartphone-based lactate dehydrogenase test

for neonatal diagnostics at the point of care // Sci. Rep. 2019. Vol. 9, no. 1. P. 9301.

232.Hamilton J.A., Vairo G., Lingelbach S.R. CSF-1 stimulates glucose uptake in murine bone marrow-derived macrophages // Biochem. Biophys. Res. Commun. 1986. Vol. 138, no. 1. P. 445-454.

233.Hariyanto T.I., Kurniawan A. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection // Diabetes Metab. Syndr.‒2020.‒Vol. 14, no. 6.‒P. 1613-1615.

234.Haschemi A., Kosma P., Gille L., Evans C.R., Burant C.F., Starkl P., Knapp B., Haas R., Schmid J.A., Jandl C., Amir S., Lubec G., Park J., Esterbauer H., Bilban M., Brizuela L., Pospisilik J.A., Otterbein L.E., Wagner O. The sedoheptulose kinase CARKL directs macrophage

polarization through control of glucose metabolism // Cell. Metab. 2012. Vol. 15, no. 6. P. 813826.

235.Haubrich B.A., Ramesha C., Swinney D.C. Development of a Bioluminescent HighThroughput Screening Assay for Nicotinamide Mononucleotide Adenylyltransferase (NMNAT)

//SLAS Discov.‒2020.‒Vol. 25, no. 1.‒P. 33-42.

236.Hayashi R., Nakatani H., Kawahata H., Fujie R., Kurowarabe K., Hayasaka H. Firefly luciferase-based chronological measurement of effector CD8+ T-cell activity using a multichamber luminometer // Bioanalysis.‒2022.‒Vol. 14, no. 22.‒P. 1413-1421.

237.Hemilä H. Vitamin C and Infections // Nutrients.‒2017.‒Vol. 9, no. 4.‒P. 339.

238.Hemilä H., Carr A., Chalker E. Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial // Front. Immunol.‒2021.‒Vol. 12.‒674681.

239.Hemilä H., Chalker E. Vitamin C as a Possible Therapy for COVID-19 // Infect. Chemother.‒ 2020.‒Vol. 52, no. 2.‒P. 222-223.

240.Hezam K., Wang C., Fu E., Zhou M., Liu Y., Wang H., Zhu L., Han Z., Han Z.C., Chang Y., Li Z. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation // Stem Cell. Res. Ther.‒2023.‒ Vol. 14, no. 1.‒P. 48.

241.Hikosaka K., Kim J., Kajita M., Kanayama A., Miyamoto Y. Platinum nanoparticles have an activity similar to mitochondrial NADH:ubiquinone oxidoreductase // Colloids Surf. B Biointerfaces.‒2008.‒Vol. 66, no. 2.‒P. 195-200.

242.Hilkens C.M.U., Diboll J., Cooke F., Anderson A.E. In Vitro Generation of Human Tolerogenic Monocyte-Derived Dendritic Cells // Methods Mol. Biol.‒2023.‒Vol. 2654.‒P. 477492.

243.Hilser J.R., Han Y., Biswas S., Gukasyan J., Cai Z., Zhu R., Tang W.H.W., Deb A., Lusis A.J., Hartiala J.A., Allayee H. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection // J. Lipid Res.‒2021.‒Vol. 62.‒100061.

244.Hirabara S.M., Gorjao R., Levada-Pires A.C., Masi L.N., Hatanaka E., Cury-Boaventura M.F., da Silva E.B., Santos-Oliveira L.C.D., Sousa Diniz V.L., Serdan T.A.D., de Oliveira V.A.B., de Souza D.R., Gritte R.B., Souza-Siqueira T., Zambonatto R.F., Pithon-Curi T.C., Bazotte R.B., Newsholme P., Curi R. Host cell glutamine metabolism as a potential antiviral target

//Clin. Sci. (Lond).‒2021.‒Vol. 135, no. 2.‒P. 305-325.

245.Ho P.C., Bihuniak J.D., Macintyre A.N., Staron M., Liu X., Amezquita R., Tsui Y.C., Cui G., Micevic G., Perales J.C., Kleinstein S.H., Abel E.D., Insogna K.L., Feske S., Locasale J.W., Bosenberg M.W., Rathmell J.C., Kaech S.M. Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses // Cell.‒2015.‒Vol. 162, no. 6.‒P. 1217-1228.

434

https://t.me/medicina_free

246.Holford P., Carr A.C., Jovic T.H., Ali S.R., Whitaker I.S., Marik P.E., Smith A.D. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19 // Nutrients.‒2020.‒ Vol. 12, no. 12.‒P. 3760.

247.Holick M.F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention // Rev. Endocr. Metab. Disord.‒2017.‒Vol. 18, no. 2.‒P. 153-165.

248.Hopewell E.L., Cox C. Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment // Mol. Ther. Methods Clin. Dev.‒2020.‒Vol. 16.‒P. 155-160.

249.Horowitz R.I., Freeman P.R. Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials // Med. Hypotheses.‒2020.‒Vol. 143.‒109851.

250.Hosaka S., Obuki M., Nakajima J., Suzuki M. Comparative study of antioxidants as quenchers or scavengers of reactive oxygen species based on quenching of MCLA-dependent

chemiluminescence // Luminescence. 2005. Vol. 20, no 6. P. 419-427.

251.Hu X., Chen D., Wu L., He G., Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection // Clin. Chim. Acta.‒2020.‒Vol. 510.‒P. 105110.

252.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet.‒2020.‒Vol. 395, no. 10223.‒P. 497-506.

253.Huang S.C., Everts B., Ivanova Y., O'Sullivan D., Nascimento M., Smith A.M., Beatty W., Love-Gregory L., Lam W.Y., O'Neill C.M., Yan C., Du H., Abumrad N.A., Urban J.F. Jr., Artyomov M.N., Pearce E.L., Pearce E.J. Cell-intrinsic lysosomal lipolysis is essential for

alternative activation of macrophages // Nat. Immunol. 2014. Vol. 15, no. 9. P. 846-855.

254.Iberg C.A., Hawiger D. Natural and Induced Tolerogenic Dendritic Cells // J. Immunol.‒ 2020.‒Vol. 204, no. 4.‒P. 733-744.

255.Ichibangase T., Ohba Y., Kishikawa N., Nakashima K., Kuroda N. Evaluation of lophine derivatives as L-012 (luminol analog)-dependent chemiluminescence enhancers for measuring

horseradish peroxidase and H2O2 // Luminescence. 2014. Vol. 29, no 2. P. 118-121.

256. Infantino V., Convertini P., Cucci L., Panaro M.A., Di Noia M.A., Calvello R., Palmieri F., Iacobazzi V. The mitochondrial citrate carrier: a new player in inflammation // Biochem J. 2011. Vol. 438, no. 3. P. 433-436.

257.Izzo R., Trimarco V., Mone P., Aloè T., Capra Marzani M., Diana A., Fazio G., Mallardo M., Maniscalco M., Marazzi G., Messina N., Mininni S., Mussi C., Pelaia G., Pennisi A., Santus P., Scarpelli F., Tursi F., Zanforlin A., Santulli G., Trimarco B. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey // Pharmacol. Res.‒2022.‒Vol. 183.‒106360.

258.Janssen R., Visser M.P.J., Dofferhoff A.S.M., Vermeer C., Janssens W., Walk J. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019 // Br. J. Nutr.‒2021.‒Vol. 126, no. 2.‒P. 191-198.

259.Jeng L.B., Liao L.Y., Shih F.Y., Teng C.F. Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies // Cancers (Basel).‒ 2022.‒Vol. 14, no. 18.‒P. 4380.

260.Jeong J., Suh Y., Jung K. Context Drives Diversification of Monocytes and Neutrophils in

Orchestrating the Tumor Microenvironment // Front. Immunol. 2019. Vol. 10. 1817.

261. Jha A.K., Huang S.C., Sergushichev A., Lampropoulou V., Ivanova Y., Loginicheva E., Chmielewski K., Stewart K.M., Ashall J., Everts B., Pearce E.J., Driggers E.M., Artyomov M.N. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization // Immunity. 2015. Vol. 42, no. 3. P. 419-430.

262. Jia H., Liu C., Li D., Huang Q., Liu D., Zhang Y., Ye C., Zhou D., Wang Y., Tan Y., Li K., Lin F., Zhang H., Lin J., Xu Y., Liu J., Zeng Q., Hong J., Chen G., Zhang H., Zheng L., Deng X.,

435

https://t.me/medicina_free

311.Liu Y., Lv J., Liu J., Li M., Xie J., Lv Q., Deng W., Zhou N., Zhou Y., Song J., Wang P., Qin C., Tong W.M., Huang B. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 // Cell Res.‒2020.‒Vol. 30, no. 12.‒P. 1078-1087.

312.Liu Z. Antioxidant activity of the thioredoxin system // Biophys. Rep.‒2023.‒Vol. 9, no. 1.‒

P.26-32.

313.Lomakina G.Y., Ugarova N.N. Bioluminescent test systems based on firefly luciferase for studying stress effects on living cells // Biophys. Rev.‒2022.‒Vol. 14, no. 4.‒P. 887-892.

314.Loucera C., Peña-Chilet M., Esteban-Medina M., Muñoyerro-Muñiz D., Villegas R., LopezMiranda J., Rodriguez-Baño J., Túnez I., Bouillon R., Dopazo J., Quesada Gomez J.M. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients // Sci. Rep.‒2021.‒Vol. 11, no. 1.‒P. 23380.

315.Lyublinskaya O.G., Zenin V.V., Shatrova A.N., Aksenov N.D., Zemelko V.I., Domnina A.P., Litanyuk A.P., Burova E.B., Gubarev S.S., Negulyaev Y.A., Nikolsky N.N. Intracellular oxidation of hydroethidine: compartmentalization and cytotoxicity of oxidation products // Free Radic. Biol. Med.‒2014.‒Vol. 75.‒P. 60-68.

316.Ma Y., Shi L., Lu P., Yao S., Xu H., Hu J., Liang X., Liang X., Wei S. Creation of a Novel Nomogram Based on the Direct Bilirubin-To-Indirect Bilirubin Ratio and Lactate Dehydrogenase Levels in Resectable Colorectal Cancer // Front. Mol. Biosci.‒2021.‒Vol. 8.‒751506.

317.Maeda H., Yamamoto K., Nomura Y., Kohno I., Hafsi L., Ueda N., Yoshida S., Fukuda M., Fukuyasu Y., Yamauchi Y., Itoh N. A design of fluorescent probes for superoxide based on a nonredox mechanism // J. Am. Chem. Soc.‒2005.‒Vol. 127, no 1.‒P. 68-69.

318.Mann E.R., Menon M., Knight S.B., Konkel J.E., Jagger C, Shaw T.N., Krishnan S., Rattray M., Ustianowski A., Bakerly N.D., Dark P., Lord G., Simpson A., Felton T., Ho L.P.; NIHR Respiratory TRC; Feldmann M.; CIRCO,; Grainger J.R., Hussell T. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19 // Sci. Immunol.‒2020.‒Vol. 5, no. 51.‒eabd6197.

319.Marcello A., Civra A., Milan Bonotto R., Nascimento Alves L., Rajasekharan S., Giacobone C., Caccia C., Cavalli R., Adami M., Brambilla P., Lembo D., Poli G., Leoni V. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID19 patients // Redox. Biol.‒2020.‒Vol. 36.‒101682.

320.Marmonti E., Oliva-Ramirez J., Haymaker C. Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer // Cells.‒2022.‒Vol. 11, no. 19.‒P. 3028.

321.Mathew D., Giles J.R., Baxter A.E., Oldridge D.A., Greenplate A.R., Wu J.E., Alanio C., Kuri-Cervantes L., Pampena M.B., D'Andrea K., Manne S., Chen Z., Huang Y.J., Reilly J.P., Weisman A.R., Ittner C.A.G., Kuthuru O., Dougherty J., Nzingha K., Han N., Kim J., Pattekar A., Goodwin E.C., Anderson E.M., Weirick M.E., Gouma S., Arevalo C.P., Bolton M.J., Chen F., Lacey S.F., Ramage H., Cherry S., Hensley S.E., Apostolidis S.A., Huang A.C., Vella L.A.; UPenn COVID Processing Unit; Betts M.R., Meyer N.J., Wherry E.J. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications // Science.‒ 2020.‒Vol. 369, no. 6508.‒eabc8511.

322.Medha Pandya, Sejal Shah, Dhanalakshmi Menamadathil, Ayushman Gadnayak, Tanzil Juneja, Amisha G. Patel, K. Das, Jayashankar Das Unravelling Vitamins as Wonder Molecules for Covid-19 Management via Structure-based Virtual Screening // Preprint: https://doi.org/10.21203/rs.3.rs-144177/v1

323.Medina E., Hartl D. Myeloid-Derived Suppressor Cells in Infection: A General Overview //

J.Innate Immun.‒2018.‒Vol. 10, no. 5-6.‒P. 407-413.

324.Mégarbane B. Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful? // J. Pers. Med.‒2022.‒Vol. 12, no. 10.‒P. 1627.

325.Meier J.L. Metabolic mechanisms of epigenetic regulation // ACS Chem. Biol. 2013. Vol. 8, no. 12. P. 2607-2621.

439

https://t.me/medicina_free